Sign in to continue:

Sunday, February 22nd, 2026

Destra Multi-Alternative Fund Announces Board Member Resignation and Provides Fund Updates

Destra Multi-Alternative Fund Announces Board Member Resignation: Key Details for Investors

Bozeman, MT – February 19, 2026 – The Destra Multi-Alternative Fund (“DMA” or the “Fund”), a closed-end fund traded on the New York Stock Exchange under the symbol DMA, has announced a notable change to its Board of Trustees. Paul Kazarian, a member of the Fund’s Board of Trustees, has voluntarily resigned from his position, effective February 12, 2026.

Key Points Investors Should Note

  • Board Resignation: Paul Kazarian’s resignation from the Board of Trustees is effective immediately as of February 12, 2026. The Board has officially acknowledged and thanked Mr. Kazarian for his contributions and service during his tenure, wishing him continued success in future endeavors.
  • Potential Impact on Governance and Strategy: Board member changes can sometimes indicate shifts in fund governance or strategy. While no specific reason for Mr. Kazarian’s resignation was provided, such departures may be scrutinized for underlying strategic or operational reasons that could affect investor sentiment.
  • Ongoing Board Updates: The Fund stated it will announce any further updates regarding its Board composition as appropriate. Investors should monitor future announcements for indications of new appointments or changes in leadership direction.

About Destra Multi-Alternative Fund

DMA is positioned as a core alternative investment solution, aiming to deliver long-term performance that is non-correlated to broad stock and bond markets. The Fund’s strategy is diversified across a range of alternative asset classes and strategies, including:

  • Real estate
  • Direct private equity
  • Alternative credit
  • Hedge strategies

These alternative approaches are designed to mitigate risk and provide unique return streams compared to traditional equity and fixed income markets.

Fund Management and Advisory Details

  • Destra Capital Advisors LLC is the Investment Adviser and Secondary Market Servicing Agent to the Fund. The firm is headquartered in Bozeman, Montana.
  • Validex Global Investing (Validus Growth Investors LLC, dba Validex Global Investing) serves as the Investment Sub-Adviser. Validex specializes in asymmetric risk-reward strategies targeting high-growth opportunities at key market inflection points. Their solutions include option-enhanced portfolios, hedging for concentrated equity positions, structured notes, and pre-IPO strategies. Their client base includes wealth advisers, family offices, and institutional investors.

Shareholder Information and Next Steps

  • Share Trading: DMA shares are available for purchase on the New York Stock Exchange through any securities broker.
  • Investor Resources: Further information about the Fund, including its distribution policy and monthly dividends, can be found at www.destracapital.com. Investors can also reach Destra Capital Advisors for marketing and investor support at [email protected] or by calling (877) 855-434.

Why This News May Be Price Sensitive

  • Leadership Changes: Changes in Board composition are significant for investors because they may signal shifts in fund direction, governance practices, or internal dynamics. While the announcement does not cite any specific concerns, investors often view board departures—especially voluntary ones—through a lens of caution, as they may precede further organizational changes or reflect broader industry trends.
  • Potential for Strategic Shifts: If the Fund were to alter its investment strategy or bring in new leadership with a different vision, this could impact the Fund’s risk/return characteristics and ultimately its share price.

Conclusion

Investors are encouraged to remain attentive to future updates from Destra Multi-Alternative Fund regarding Board composition and any strategic developments. Changes in fund leadership, especially at the Board level, can have both immediate and longer-term implications for fund performance and investor confidence.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with their financial advisers before making investment decisions. Past performance is not indicative of future results.

View Destra Multi-Alternative Fund Historical chart here



Pulse Biosciences, Inc. 2024 Financial Results and SEC Filing Details

Pulse Biosciences Reports Q4 and Full Year 2025 Results: Business Update & Financial Analysis Pulse Biosciences, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results and Business Updates Key Highlights Date of Announcement:...

iAnthus Capital Announces Florida Dispensary Expansion, New Brand Launches, and Bridge Note Extension

iAnthus Capital Holdings Announces Florida Expansion, Brand Launches, and Debt Extension: Key Updates for Investors NEW YORK, NY and TORONTO, ON – February 17, 2026 – iAnthus Capital Holdings, Inc. (CSE: IAN, OTCID: ITHUF),...

Strawberry Fields REIT Reports Record 2025 Operating Results with Strong FFO Growth, Major Acquisitions, and Expanded Healthcare Portfolio

Strawberry Fields REIT Announces Outstanding 2025 Year-End Results and Strategic Expansion Strawberry Fields REIT Reports Record 2025 Results, Aggressive Expansion, and Strong FFO Growth South Bend, IN – February 19, 2026: Strawberry Fields REIT,...

   Ad